Brief Reports Open Access
Copyright ©The Author(s) 2000. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Jun 15, 2000; 6(3): 445-447
Published online Jun 15, 2000. doi: 10.3748/wjg.v6.i3.445
Effects of radical cholecystectomy on nutritional and immune status in patients with gallbladder carcinoma
Xing-Yuan Jiao, Jing-Sen Shi, Jian-Sheng Wang, Yi-Jun Yang and Ping He, Hepatobiliary Research Lab, First Affiliated Hospital of Xi′an Medical University, Xi′an 710061, Shaanxi Province, China
Author contributions: All authors contributed equally to the work.
Correspondence to: Xing-Yuan Jiao, Hepatobiliary Research Lab, First Affiliated Hospital of Xi′an Medical University, Xi′an 710061, Shaanxi Province, China
Telephone: +86-29-5261696
Received: January 18, 2000
Revised: March 3, 2000
Accepted: March 14, 2000
Published online: June 15, 2000

Abstract
Key Words: gallbladder neoplasms/immunology, cholecystectomy, nutritional status, immune status



INTRODUCTION

Carcinoma of the gallbladder is the most common neoplasm in biliary tract, and its incidence has been rising in recent years. The rate of correct diagnosis in early gallbladder carcinoma has been raised after the wide use of CT, ultrasound scans and frozen section examination. Now radical cholecystectomy is advocated as the best management for patients with early gallbladder carcinoma. In the present study, the diagnosis of 27 patients with gallbladder carcinoma was confirmed correct, and the patients underwent radical cholecystectomy, and their nutritional and immune assessments were performed pre- and post-operatively.

PATIENTS AND METHODS
Patients

From September 1993 to December 1997, 27 patients with gallbladder carcinoma who had undergone radical cholecystectomy were selected, and they were admitted to the First an d Second Affiliated Hospitals of Xi′an Medical University. The patients include d, eight males, aged 46-65 years, with a mean of 57 years; ninteen females, aged 50-67 years, with the mean of 59 years. Four patients were diagnosed as having polyposis preoperatively, and diagnosed as carcinoma during the operation by the frozen section technique. In five patients with preoperative diagnosis of carcinoma, metastasis had not been found during the operation. No severe systemic disease was found, e.g. recent myocardial infarction, cerebral vascular accidents, uncontrollable diabetes mellitus or hypertension. Antibiotics was administered postoperatively to prevent infection, intravenous infusion was rountinely administered immediately after surgery and maintained at least for one week. The tumors were graded as stage I, II and III (Nevin stage) by histological examination. All of the resected specimens were sent for histological examination. No chemotherapy or radiotherapy was administered preoperatively.

Methods

The nutritional and immune status of the patients were assessed preoperatively (1 wk before surgery), and on d3, d7, d14 and d21 postoperatively.

Nutritional assessment Biochemical parameters evaluating the patient′s nutritional status consisted of serum levels of albumin, cholesterol, iron, magnesium, zinc, and transferrin determined by an automated calorimetric technique (SMAC), and total iron binding capacity (TIBC) determined by radio immunodiffusion.

Immune studies The immune status includes T lymphocyte subpopulation-CD4, CD8; immunoglobulins (IgG, IgA and IgM); complements (C3 and C4); and serum interleukin-2 and soluble interleukin-2 receptor were evaluated. T lymphocyte subpopulation assessment: blood samples we re taken with venopuncture and anticoagulated by heparin. Mononuclear cells were isolated after the sample had been washed twice with Hank′s balanced salt solution, and the concentration of the cells was regulated at 2 × 102/mL with PRMI-1840 (Cow serum). Cell suspensions (0.2 mL) were placed in 24-well plates, and added cow serum 0.1 mL, PHA 0.05 mL, LPS 0.05 mL and 10% RPMI-1640 0.6 mL respectively. The plates were incubated at 37 °C with 5% CO2 for 72 h. Cultured supernatants was harvested and kept at -30 °C. The cell suspension was assigned equally into three parts, which was washed once, added with CD4 and CD8 monoclonal antibody (monoclonal antibody was provided by Luo Yang Hua Mei Co.), stand for 2 h at 4 °C; then each was washed twice again; a sheep-anti-mouse IgG fluo resent antibody 50 μL was added into each tube, stand for 2 h at 4 °C, and washed twice again. After harvesting, cell suspension was studied under the fluoresence microscopy and the scintillation cells were quantitated as percentage of 100 or 200 lymphocytes.

Assay of IgA, IgG, IgM and complements Serum IgG, IgA, IgM, C 3 and C4 were quantitated by nephelometric immunoassay.

Assay of serum IL-2, sIL-2R Serum IL-2 and sIL-2 levels wer e measured by a "Sandwich" enzyme-linked immunosorbent assay with two antibod ies, the diagnostic reagents were supplied by Norman Bethune Medical University.

Statistical analysis

For each variable, multiple analysis of variance for repeated measurements was used to compare the values measured before operation with those measured at four subsequent time points. The results were presented as mean and standard error (-x±s) based on the mixed model of repeated measurment analysis. Statisical analysis was performed with SAS software. P values < 0.05 were considered statistically significant.

RESULTS

The results of the nutritional and immunological assessment at various time points are demonstrated in Table 1.

Table 1 Nutritional and immunity status in patients with gallbladder carcinoma (-x±s).
ParametersPreoperativePostoperative
3rd day1st week2nd week3rd week
Nutrition
Albumin (g/mL)3.6 ± 0.073.01 ± 0.14b3.49 ± 0.13a3.50 ± 0.123.58 ± 0.15
Cholesterol (mg/dL)215 ± 7.8178.16 ± 7.22b85.23 ± 7.41b131.45 ± 6.85b148.62 ± 8.41b
TIBC (μg/dL)251.15 ± 12.95129.18 ± 8.15b162.67 ± 9.83b194.15 ± 10.15b199.34 ± 9.68b
Transferrin (mg/dL)221.07 ± 12.1199.77 ± 8.98b131.29 ± 9.01b175.25 ± 9.31b186.21 ± 10.18b
Iron (mg/dL)65.12 ± 6.1523.39 ± 4.93b23.41 ± 5.01b32.47 ± 5.42b39.87 ± 5.87b
Magnesium (mg/dL)2.13 ± 0.061.57 ± 0.05b1.99 ± 0.05b2.04 ± 0.062.06 ± 0.06
Zinc (mg/dL)106.1 ± 3.5659.85 ± 5.13b88.66 ± 4.43b105.8 ± 3.71109.9 ± 3.81
Immunity
C3 (mg/dL)148.1 ± 5.1570.21 ± 5.6b96.23 ± 4.68b118.56 ± 5.11a123.73 ± 6.22
C4 (mg/dL)25.15 ± 1.1514.38 ± 1.41b18.79 ± 1.45a24.82 ± 1.2124.98 ± 1.16
T lymphocyte subpoulation
CD4 (%)44.15 ± 2.0133.22 ± 1.88b39.96 ± 2.02b42.37 ± 2.00a43.99 ± 1.97
CD8 (%)34.12 ± 1.6929.47 ± 3.77b26.21 ± 3.13b39.69 ± 3.00b35.81 ± 1.20
CD4/CD8 (ratio)1.3 ± 0.181.1 ± 0.08b1.5 ± 0.19b1.07 ± 0.14b1.20 ± 0.16b
IL-2 (IU/mL)9.95 ± 2.954.81 ± 1.81b5.99 ± 2.30b8.41 ± 2.93a9.89 ± 3.01
sIL-2R (U/mL)754.2 ± 141.5478.3 ± 87.57b597.4 ± 96.81b692.1 ± 112.6748.9 ± 138.8
Preoperation

As shown in Table 1, in patients with gallbladder carcinoma, the preoperative nutritional and immune status was all within the assigned normal ranges.

Third postoperative day

All the nutritional parameters decreased greatly after surgery, especially the serum iron, transferrin, cholesterol, TIBC, magnesium, and zinc (P < 0.01, respectively).

The serum levels of immunoglobulins (IgA, IgG, IgM) and C3, C4 complements decreased significantly (P < 0.01), serum IL-2 levels, CD4 and CD4 levels also reduced greatly (P < 0.01), and CD8 and sIL- 2R levels increased significantly (P < 0.01).

First postoperative week

Compared with the third postoperative day, all the nutritional parameters increased slightly, particularly the serum albumin, magnesiumal. Serum cholesterol, TIBC, transferrin, iron and zinc were still lower than their preoperative levels (P < 0.01). CD4, CD8, CD4/CD8, IL-2, sIL-2 values differed significantly from those of the preoperative stage(P < 0.01). The serum levels of immunoglobulins (IgG, IgA, IgM) and complements (C3 and C4) were significantly higher than those of the third postoperative day, but they were still lower than those of the preoperative day.

Second postoperative week

Compared with the third postoperative day and the first postoperative week, albumin, magnesium and zinc recovered to the preoperative levels (P > 0.05), however, the levels of TIBC, transferrin and iron were still significantly lower than those of the preoperative ones (P < 0.01). Compared with the third postoperative day and the first postoperative week, the serum levels of immunoglobulins (IgG, IgA, IgM) and complements (C3 and C4) gradually recovered, and IL-2, CD4, CD8, sIL-2R levels and CD4/CD8 ratio were not statistically different from the preoperative levels.

Third postoperative week

The nutritional evaluation showed continous improvement in the third postoperative week, most of the nutritional parameters returned to the preoperative levels, except for the serum levels of iron, transferrin and TIBC. The immune parameter s IL-2, sIL-2R, CD4, CD 8, CD4/CD8 ratio, C3, C4 immunoglobulin levels (IgG, IgA, IgM) also returned to the preoperative levels, with no statistical difference (P > 0.05).

DISCUSSION

Carcinoma of the gallbladder is one of the most common neoplasms in biliary tract, and 40%-100% cases are complicated with gallstones[1,2], but correct diagnosis of gallbladder carcinoma in its early stage accounted for only 19.1%, and 53.3% cases are always diagnosed as cholecystitis and gal lstone[3-5]. More and more clinical experiences indicate that radical cholecystectomy for early carcinoma is the most effective treatment[6-8]. In the present study, though all patients with gallbladder carcinoma were well prepared to receive the radical cholecystectomy, their nutritional and immune status still deteriorated remarkably immediately after the extensive surgical resection. The reasons might be that: ① Large volume of body fluid lost during and after the surgery; ② the radical cholecystectomy is a complex operation needing long time and wide scope of resection. Sumiyoshi[9] and Wang et al[10] studied the effect of surgery as an injury factor on nutritional and immune status in patients with carcinoma, it is coincident with our findings in this report. Our investigation showed that all of the nutritional parameters but the serum levels of iron, TIBC and transferrin recovered within 3 wk after operation. Hickey et al[11] advocated that supplemental vitamins and minerals, e.g. iron should be given postoperatively when deficiencies are suspected. Our conclusion is that adequate iron should be supplemented after the radical cholecystectomy for gallbladder carcinoma in the third postoperative week, and the serum levels of minerals should be monitored rountinely after surgery.

The immune study showed remarkable decrease of serum IgA, IgM, IgG and C3, C4 complement, IL-2, CD4, CD4/CD8 ratio, and the remarkable increase of serum SIL-2R and CD8 (P < 0.01) on d3 after operation. IL-2 is a T-cell derived soluble lymphokine whose main bioactivity is to stimulate the activated T cell (Th, Ts, Tc) to reproduce continually, proliferate and is the key mediator in cell and humoral immunity and immune regulation. The balance between IL-2 and its receptor regulates the immune status. T cell serves as the center in controlling cellular immune status which can affect directly the occurrence, development and progression of tumor[12]. T cell ′s regulating function is mainly performed by CD4 and CD8 T cells. CD4+ T cells can help B cell produce antibody and CD8+ T cells can suppress B cell to produce antibody. The stable balance between them keeps normal immune response of the organism. Surgery, as an injurious factor, broke the balance between CD4 and CD8, however T cell′s immune regulating function is demanded finally by the organism. In gallbladder carcinoma in an early stage, the serum IL-2, CD4, CD8, CD4/CD8 ratio, sIL-2R recovered remarkably in the first postoperative week. In early postoperative stage, the serum levels of immunoglobulins and complement reduced remarkably. This evidence suggests the results are possibly influenced by surgical stress and the diluting effect of the postoperative massive fluid therapy. The immune parameters returned to the preoperative levels within 2-3 wk after surgery, suggesting that T cell plays a more importent role in the immune regulating system.

The present study suggests that radical cholecystectomy for early gallbladder carcinoma might have a mild and transient adverse effect on the cell-mediated immune response during the early postoperative period. Because of tumor′s own direct products, tumor cell′s metabolites and immuno-complex in body circulation, which depress the anti-tumor action of the immune cells[13,14], patients′ immune status deteriorated remarkably in the middle and late stage. For gallbladder carcinoma, radical cholecystectomy in its early stage with complete resection of the tumor and removal of lymphnodes should be perform ed, thus the immune inhibitors in the tumor mass can be excluded. These factors played important roles in the recovery of immune function.

Footnotes

Xing-Yuan Jiao, graduated from Xi′an Medical University with bachelor degree in 1991 and master degree in 1997 in the same university, now studying for doctor degree in general surgery, having 4 papers published.

Edited by You DY and Ma JY

proofread by Sun SM

References
1.  Shi J, Zhou L, Wang Z. [Retrospective analysis of 830 extrahepatic biliary carcinoma]. Zhonghua Waike Zazhi. 1997;35:645-648.  [PubMed]  [DOI]  [Cited in This Article: ]
2.  Ekbom A, Hsieh CC, Yuen J, Trichopoulos D, McLaughlin JK, Lan SJ, Adami HO. Risk of extrahepatic bileduct cancer after cholecystectomy. Lancet. 1993;342:1262-1265.  [PubMed]  [DOI]  [Cited in This Article: ]
3.  Chijiiwa K, Sumiyoshi K, Nakayama F. Impact of recent advances in hepatobiliary imaging techniques on the preoperative diagnosis of carcinoma of the gallbladder. World J Surg. 1991;15:322-327.  [PubMed]  [DOI]  [Cited in This Article: ]
4.  Henson DE, Albores-Saavedra J, Corle D. Carcinoma of the gallbladder. Histologic types, stage of disease, grade, and survival rates. Cancer. 1992;70:1493-1497.  [PubMed]  [DOI]  [Cited in This Article: ]
5.  Sumiyoshi K, Nagai E, Chijiiwa K, Nakayama F. Pathology of carcinoma of the gallbladder. World J Surg. 1991;15:315-321.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 47]  [Cited by in F6Publishing: 47]  [Article Influence: 1.4]  [Reference Citation Analysis (0)]
6.  Busse PM, Cady B, Bothe A, Jenkins R, McDermott WV, Steele G, Stone MD. Intraoperative radiation therapy for carcinoma of the gallbladder. World J Surg. 1991;15:352-356.  [PubMed]  [DOI]  [Cited in This Article: ]
7.  Gagner M, Rossi RL. Radical operations for carcinoma of the gallbladder: present status in North America. World J Surg. 1991;15:344-347.  [PubMed]  [DOI]  [Cited in This Article: ]
8.  Gall FP, Köckerling F, Scheele J, Schneider C, Hohenberger W. Radical operations for carcinoma of the gallbladder: present status in Germany. World J Surg. 1991;15:328-336.  [PubMed]  [DOI]  [Cited in This Article: ]
9.  Mulvihill SJ, Pellegrini CA. Postoperative care. 10th editor. VS: Lange Medical Publication 1994; 15-23.  [PubMed]  [DOI]  [Cited in This Article: ]
10.  Wang LS, Lin HY, Chang CJ, Fahn HJ, Huang MH, Lin CF. Effects of en bloc esophagectomy on nutritional and immune status in patients with esophageal carcinoma. J Surg Oncol. 1998;67:90-98.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in F6Publishing: 1]  [Reference Citation Analysis (0)]
11.  Hickey MS, Arbeit JM, Way LW. Surgical metabolism and nutrition. 10th ed. VS: Lange Medical Publication 1994; 143-194.  [PubMed]  [DOI]  [Cited in This Article: ]
12.  Lotze MT, Finn OJ. Recent advances in cellular immunology: implications for immunity to cancer. Immunol Today. 1990;11:190-193.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 22]  [Cited by in F6Publishing: 24]  [Article Influence: 0.7]  [Reference Citation Analysis (0)]
13.  Jiao XY, Shi JS, Gao JS, Zhou LS. Determination of levels of cellular immunity and humoral immunity in patients with gallbladder carcinoma. Zhongguo Puwai Jichu Yu Lingchuang Zazhi. 1999;6:227-229.  [PubMed]  [DOI]  [Cited in This Article: ]
14.  Jiao XY, Shi JS, Gao JS, Zhou LS, Han WS, Liu G, Lu Y. Study on the serum Il-2, sIL-2R and CEA levels in patients with gallbladder carcinoma. Zhonghua Gandan Waike Zazhi. 1999;5:342.  [PubMed]  [DOI]  [Cited in This Article: ]